The immune response of the human brain to abdominal surgery

Annals of Neurology

Volumn 81, Issue 4, 2017, Pages 572-582

  Forsberg, Anton ^a   Cervenka, Simon ^a   Jonsson Fagerlund, Malin ^a,b   Rasmussen, Lars S ^c   Zetterberg, Henrik ^d,e,f   Erlandsson Harris, Helena ^a,b   Stridh, Pernilla ^a   Christensson, Eva ^a,b   Granström, Anna ^a,b   Schening, Anna ^a,b   Dymmel, Karin ^a,b   Knave, Nina ^a   Terrando, Niccolò ^g   Maze, Mervyn ^h   Borg, Jacqueline ^a   Varrone, Andrea ^a   Halldin, Christer ^a   Blennow, Kaj ^d,e   Farde, Lars ^a,b   Eriksson, Lars I ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; LIPOPOLYSACCHARIDE; OXYCODONE; PARACETAMOL; PBR28 C 11; RADIOLIGAND; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ABDOMINAL SURGERY; ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BRAIN; CELL ACTIVATION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG BINDING; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; EX VIVO STUDY; GENERAL ANESTHESIA; GLIA CELL; GRAY MATTER; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; MALE; MIDDLE AGED; NEUROIMAGING; PLASMA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COGNITIVE DYSFUNCTION; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATECTOMY; ROBOT ASSISTED SURGERY; STROOP TEST; SURGICAL PATIENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ABDOMEN; ADVERSE EFFECTS; COGNITIVE DYSFUNCTION; DIAGNOSTIC IMAGING; FOLLOW UP; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; SURGERY;

ABDOMEN; AGED; BIOMARKERS; BRAIN; COGNITIVE DYSFUNCTION; DOWN-REGULATION; FOLLOW-UP STUDIES; GRAY MATTER; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSTATECTOMY;

EID: 85017430589     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24909     Document Type: Article

References (61)

1. Wan Y, Xu J, Ma D, et al. Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus. Anesthesiology 2007;106:436–443.
2. Cibelli M, Fidalgo AR, Terrando N, et al. Role of interleukin-1beta in postoperative cognitive dysfunction. Ann Neurol 2010;68:360–368.
3. Terrando N, Eriksson LI, Ryu JK, et al. Resolving postoperative neuroinflammation and cognitive decline. Ann Neurol 2011;70:986–995.
4. Tang JX, Baranov D, Hammond M, et al. Human Alzheimer and inflammation biomarkers after anesthesia and surgery. Anesthesiology 2011;115:727–732.
5. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010;464:104–107.
6. Degos V, Maze M, Vacas S, et al. Bone fracture exacerbates murine ischemic cerebral injury. Anesthesiology 2013;118:1362–1372.
7. Hirsch J, Vacas S, Terrando N, et al. Perioperative cerebrospinal fluid and plasma inflammatory markers after orthopedic surgery. J Neuroinflammation 2016;13:211.
8. Terrando N, Gomez-Galan M, Yang T, et al. Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline. FASEB J 2013;27:3564–3571.
9. Terrando N, Gómez-Galán M, Yang T, et al. Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline. FASEB J 2013;27:3564–3571.
10. Evered L, Silbert B, Scott DA, et al. Cerebrospinal fluid biomarker for Alzheimer disease predicts postoperative cognitive dysfunction. Anesthesiology 2016;124:353–361.
11. Moller JT, Cluitmans P, Rasmussen LS, et al. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 1998;351:857–861.
12. Feng X, Degos V, Koch LG, et al. Surgery results in exaggerated and persistent cognitive decline in a rat model of the metabolic syndrome. Anesthesiology 2013;118:1098–1105.
13. Reinsfelt B, Ricksten SE, Zetterberg H, et al. Cerebrospinal fluid markers of brain injury, inflammation, and blood-brain barrier dysfunction in cardiac surgery. Ann Thorac Surg 2012;94:549–555.
14. Bromander S, Anckarsäter R, Kristiansson M, et al. Changes in serum and cerebrospinal fluid cytokines in response to non-neurological surgery: an observational study. J Neuroinflammation 2012;9:242.
15. Reinsfelt B, Westerlind A, Blennow K, et al. Open-heart surgery increases cerebrospinal fluid levels of Alzheimer-associated amyloid β. Acta Anaesthesiol Scand 2013;57:82–88.
16. Hotchkiss RS, Monneret G, Payen D. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 2013;13:260–268.
17. Reikerås O, Sun J, Wang JE, Aasen AO. Postoperative serum attenuates LPS-induced release of TNF-alpha in orthopaedic surgery. J Orthop Res 2007;25:1395–1400.
18. Fahlenkamp AV, Coburn M, Rossaint R, et al. Comparison of the effects of xenon and sevoflurane anaesthesia on leucocyte function in surgical patients: a randomized trial. Br J Anaesth 2014;112:272–280.
19. Tóth M, Little P, Arnberg F, et al. Acute neuroinflammation in a clinically relevant focal cortical ischemic stroke model in rat: longitudinal positron emission tomography and immunofluorescent tracking. Brain Struct Funct 2016;221:1279–1290.
20. Ory D, Planas A, Dresselaers T, et al. PET imaging of TSPO in a rat model of local neuroinflammation induced by intracerebral injection of lipopolysaccharide. Nucl Med Biol 2015;42:753–761.
21. Fujita M, Imaizumi M, Zoghbi SS, et al. Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation. Neuroimage 2008;40:43–52.
22. Kreisl WC, Lyoo CH, McGwier M, et al. In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease. Brain 2013;136(pt 7):2228–2238.
23. Gulyas B, Toth M, Vas A, et al. Visualising neuroinflammation in post-stroke patients: a comparative PET study with the TSPO molecular imaging biomarkers [11C]PK11195 and [11C]vinpocetine. Curr Radiopharm 2012;5:19–28.
24. Oh U, Fujita M, Ikonomidou VN, et al. Translocator protein PET imaging for glial activation in multiple sclerosis. J Neuroimmune Pharmacol 2011;6:354–361.
25. Gerhard A, Pavese N, Hotton G, et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis 2006;21:404–412.
26. Shao X, Wang X, English SJ, et al. Imaging of carrageenan-induced local inflammation and adjuvant-induced systemic arthritis with [(11)C]PBR28 PET. Nucl Med Biol 2013;40:906–911.
27. 11C]PBR28 positron emission tomography in nonhuman primates. Neuroimage 2012;63:232–239.
28. Sandiego CM, Gallezot JD, Pittman B, et al. Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci U S A 2015;112:12468–12473.
29. Hines CS, Fujita M, Zoghbi SS, et al. Propofol decreases in vivo binding of 11C-PBR28 to translocator protein (18 kDa) in the human brain. J Nucl Med 2013;54:64–69.
30. Collste K, Forsberg A, Varrone A, et al. Test-retest reproducibility of [(11)C]PBR28 binding to TSPO in healthy control subjects. Eur J Nucl Med Mol Imaging 2016;43:173–183.
31. Kanegawa N, Collste K, Forsberg A, et al. In vivo evidence of a functional association between immune cells in blood and brain in healthy human subjects. Brain Behav Immun 2016;54:149–157.
32. Briard E, Zoghbi SS, Imaizumi M, et al. Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo. J Med Chem 2008;51:17–30.
33. Kreisl WC, Jenko KJ, Hines CS, et al. A genetic polymorphism for translocator protein 18 kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J Cereb Blood Flow Metab 2013;33:53–58.
34. Owen DR, Matthews PM. Imaging brain microglial activation using positron emission tomography and translocator protein-specific radioligands. Int Rev Neurobiol 2011;101:19–39.
35. Schain M, Tóth M, Cselényi Z, et al. Quantification of serotonin transporter availability with [11C]MADAM—a comparison between the ECAT HRRT and HR systems. Neuroimage 2012;60:800–807.
36. Cselényi Z, Olsson H, Halldin C, et al. A comparison of recent parametric neuroreceptor mapping approaches based on measurements with the high affinity PET radioligands [11C]FLB 457 and [11C]WAY 100635. Neuroimage 2006;32:1690–1708.
37. Jucaite A, Svenningsson P, Rinne JO, et al. Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease. Brain 2015;138(pt 9):2687–2700.
38. Kuhle J, Barro C, Andreasson U, et al. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa. Clin Chem Lab Med 2016;54:1655–1661.
39. Oliver JM, Jones MT, Kirk KM, et al. Serum neurofilament light in American football athletes over the course of a season. J Neurotrauma 2016;33:1784–1789.
40. Shahim P, Tegner Y, Wilson DH, et al. Blood biomarkers for brain injury in concussed professional ice hockey players. JAMA Neurol 2014;71:684–692.
41. Norgren N, Rosengren L, Stigbrand T. Elevated neurofilament levels in neurological diseases. Brain Res 2003;987:25–31.
42. Peng L, Xu L, Ouyang W. Role of peripheral inflammatory markers in postoperative cognitive dysfunction (POCD): a meta-analysis. PLoS One 2013;8:e79624.
43. Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med 2011;208:2581–2590.
44. Canat X, Carayon P, Bouaboula M, et al. Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. Life Sci 1993;52:107–118.
45. Venneti S, Lopresti BJ, Wiley CA. Molecular imaging of microglia/macrophages in the brain. Glia 2013;61:10–23.
46. Airas L, Dickens AM, Elo P, et al. In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis. J Nucl Med 2015;56:305–310.
47. Lavisse S, Guillermier M, Hérard AS, et al. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J Neurosci 2012;32:10809–10818.
48. Prinz M, Priller J. Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat Rev Neurosci 2014;15:300–312.
49. Kreisl WC, Fujita M, Fujimura Y, et al. Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: implications for positron emission tomographic imaging of this inflammation biomarker. Neuroimage 2010;49:2924–2932.
50. Park E, Gallezot JD, Delgadillo A, et al. (11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas. Eur J Nucl Med Mol Imaging 2015;42:1081–1092.
51. Loggia ML, Chonde DB, Akeju O, et al. Evidence for brain glial activation in chronic pain patients. Brain 2015;138(pt 3):604–615.
52. Zürcher NR, Loggia ML, Lawson R, et al. Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28. Neuroimage Clin 2015;7:409–414.
53. Lyoo CH, Ikawa M, Liow JS, et al. Cerebellum can serve as a pseudo-reference region in Alzheimer disease to detect neuroinflammation measured with PET radioligand binding to translocator protein. J Nucl Med 2015;56:701–706.
54. Gershen LD, Zanotti-Fregonara P, Dustin IH, et al. Neuroinflammation in temporal lobe epilepsy measured using positron emission tomographic imaging of translocator protein. JAMA Neurol 2015;72:882–888.
55. Ye X, Lian Q, Eckenhoff MF, et al. Differential general anesthetic effects on microglial cytokine expression. PLoS One 2013;8:e52887.
56. Yuki K, Eckenhoff RG. Mechanisms of the immunological effects of volatile anesthetics: a review. Anesth Analg 2016;123:326–335.
57. López-Collazo E, del Fresno C. Pathophysiology of endotoxin tolerance: mechanisms and clinical consequences. Crit Care 2013;17:242.
58. Freudenberg MA, Galanos C. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages. Infect Immun 1988;56:1352–1357.
59. Le Maître E, Revathikumar P, Idborg H, et al. Impaired vagus-mediated immunosuppression in microsomal prostaglandin E synthase-1 deficient mice. Prostaglandins Other Lipid Mediat 2015;121(pt B):155–162.
60. del Fresno C, García-Rio F, Gómez-Piña V, et al. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J Immunol 2009;182:6494–6507.
61. Tracey KJ. Reflex control of immunity. Nat Rev Immunol 2009;9:418–428.